Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes

NCT04219085 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT04219085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04219085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2020
Completion date
August 30, 2024
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes, maternal complication of pregnancy